Liom Cracks “Holy Grail” of Non-Invasive Glucose Monitoring and Secures USD >25m in Funding Kickstarting Its Series A
Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable,...